Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years

Table 6 Treatment and outcome of the patients with intrahepatic sarcomatoid cholangiocarcinoma

Case	Sex	Age	Tumor size (cm)	Number of mass	Stage (TNM)	Treatment	Outcome	F/U duration (d)
1	M	45	7.5	7	IVB	Chemotherapy	Died	47
2	M	67	2.5	1	IVB	Chemotherapy	Died	148
3	M	55	6.5	2	IVA	Chemotherapy	Died	129
4	M	66	10.0	1	IVB	Supportive	Died	20
5	M	56	8.0	1	IVB	Chemotherapy	Died	72
6	F	66	7.5	1	IVB	Chemotherapy	Died	125
7	M	68	6.0	1	IVB	Supportive	Died	19
8	F	55	8.5	3	IVA	Chemotherapy	Died	31
9	M	49	9.5	3	IVA	Chemotherapy	F/U loss	43
10	M	65	9.5	15	IVA	Supportive	Died	14
11	M	61	5.0	1	IVB	viscum album	Survived	379

F/U: Follow-up.